Weaker antibody response to first COVID-19 vaccine dose found in long-term care residents
New data stemming from a study in British Columbia evaluating the strength and magnitude of antibody responses following one dose of the Pfizer-BioNTech vaccine indicate that older adults generate a much weaker antibody response to one vaccine dose compared to younger adults.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed